[1] GBD 2019 Blindness and Vision Impairment collaborators, Vision Loss Expert Group of the Global Burden of Disease study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study[J]. Lancet Glob Health, 2021, 9(2): e144-e160.
[2] Cunningham ET Jr, Zierhut M.Uveitic Ocular Hypertension and Glaucoma[J]. Ocul Immunol Inflamm, 2017, 25(6): 737-739.
[3] Akin M, Kumar A, Kodati S, et al.Risk of Elevated Intraocular Pressure With Difluprednate in Patients With Non-Infectious Uveitis[J]. Am J Ophthalmol, 2022, 240: 232-238.
[4] Rojas-Carabali W, Mejía-Salgado G, Cifuentes-González C, et al.Prevalence and clinical characteristics of uveitic glaucoma: multicentric study in Bogotá, Colombia[J]. Eye (Lond), 2024, 38(4): 714-722.
[5] Al Rubaie K, Al Dhahri H, Al Fawaz A, et al.Incidence and Risk Factors for Developing Glaucoma Among Patients with Uveitis in a University-based Tertiary Referral Center in Riyadh, Saudi Arabia[J]. Ocu Immunol Inflamm, 2016, 24(5): 571-578.
[6] Pillai MR, Balasubramaniam N, Wala N, et al.Glaucoma in Uveitic Eyes: Long-Term Clinical Course and Management Measures[J]. Ocul Immunol Inflamm, 2024, 32(6): 1041-1047.
[7] Kesav N, Palestine AG, Kahook MY, et al.Current management of uveitis-associated ocular hypertension and glaucoma[J]. Surv Ophthalmol, 2020, 65(4): 397-407.
[8] Babu K, Konana VK, Ganesh SK, et al.Viral anterior uveitis[J]. Indian J Ophthalmol, 2020, 68(9): 1764-1773.
[9] Kitching AR, Anders HJ, Basu N, et al.ANCA-associated vasculitis[J]. Nat Rev Dis Primers, 2020, 6(1): 71.
[10] Junek ML, Zhao L, Garner S, et al.Ocular manifestations of ANCA-associated vasculitis[J]. Rheumatology (Oxford), 2023, 62(7): 2517-2524.
[11] Macarie SS, Kadar A.Eye involvement in ANCA positive vasculitis[J]. Rom J Ophthalmol, 2020, 64(1): 3-7.
[12] Durel CA, Hot A, Trefond L, et al.Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients[J]. Rheumatology (Oxford), 2019, 58(9): 1565-1573.
[13] Hinojosa-Azaola A, García-Castro A, Juárez-Flores A, et al.Clinical significance of ocular manifestations in granulomatosis with polyangiitis: association with sinonasal involvement and damage[J]. Rheumatol Int, 2019, 39(3): 489-495. |
